The Joint Statistics
Total Valuation
The Joint has a market cap or net worth of $174.76 million. The enterprise value is $155.09 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
The Joint has 15.30 million shares outstanding. The number of shares has increased by 1.82% in one year.
| Current Share Class | 15.30M |
| Shares Outstanding | 15.30M |
| Shares Change (YoY) | +1.82% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 3.06% |
| Owned by Institutions (%) | 47.26% |
| Float | 10.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 30.05 |
| PS Ratio | 3.13 |
| Forward PS | 2.96 |
| PB Ratio | 8.47 |
| P/TBV Ratio | 8.78 |
| P/FCF Ratio | 98.07 |
| P/OCF Ratio | 60.18 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 87.03 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.59 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.26 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.13% and return on invested capital (ROIC) is -2.75%.
| Return on Equity (ROE) | -7.13% |
| Return on Assets (ROA) | -1.06% |
| Return on Invested Capital (ROIC) | -2.75% |
| Return on Capital Employed (ROCE) | -4.01% |
| Revenue Per Employee | $71,725 |
| Profits Per Employee | -$11,787 |
| Employee Count | 736 |
| Asset Turnover | 0.65 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, The Joint has paid $66,964 in taxes.
| Income Tax | 66,964 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.34% in the last 52 weeks. The beta is 1.49, so The Joint's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -16.34% |
| 50-Day Moving Average | 10.66 |
| 200-Day Moving Average | 11.09 |
| Relative Strength Index (RSI) | 51.64 |
| Average Volume (20 Days) | 92,165 |
Short Selling Information
The latest short interest is 398,140, so 2.60% of the outstanding shares have been sold short.
| Short Interest | 398,140 |
| Short Previous Month | 394,261 |
| Short % of Shares Out | 2.60% |
| Short % of Float | 3.97% |
| Short Ratio (days to cover) | 6.09 |
Income Statement
In the last 12 months, The Joint had revenue of $52.79 million and -$8.68 million in losses. Loss per share was -$0.58.
| Revenue | 52.79M |
| Gross Profit | 41.01M |
| Operating Income | -1.38M |
| Pretax Income | -3.34M |
| Net Income | -8.68M |
| EBITDA | -1.04M |
| EBIT | -1.38M |
| Loss Per Share | -$0.58 |
Full Income StatementBalance Sheet
The company has $21.92 million in cash and $2.25 million in debt, giving a net cash position of $19.67 million or $1.29 per share.
| Cash & Cash Equivalents | 21.92M |
| Total Debt | 2.25M |
| Net Cash | 19.67M |
| Net Cash Per Share | $1.29 |
| Equity (Book Value) | 19.94M |
| Book Value Per Share | 1.30 |
| Working Capital | 25.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.90 million and capital expenditures -$1.12 million, giving a free cash flow of $1.78 million.
| Operating Cash Flow | 2.90M |
| Capital Expenditures | -1.12M |
| Free Cash Flow | 1.78M |
| FCF Per Share | $0.12 |
Full Cash Flow StatementMargins
Gross margin is 77.68%, with operating and profit margins of -2.62% and -16.43%.
| Gross Margin | 77.68% |
| Operating Margin | -2.62% |
| Pretax Margin | -2.99% |
| Profit Margin | -16.43% |
| EBITDA Margin | -1.96% |
| EBIT Margin | -2.62% |
| FCF Margin | 3.38% |
Dividends & Yields
The Joint does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.82% |
| Shareholder Yield | n/a |
| Earnings Yield | -4.96% |
| FCF Yield | 1.02% |
Analyst Forecast
The average price target for The Joint is $15.50, which is 35.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.50 |
| Price Target Difference | 35.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
The Joint has an Altman Z-Score of 2.4 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.4 |
| Piotroski F-Score | 5 |
